SCHEMBL1012610

SCHEMBL1012610

COc1cc2nc(Cl)ncc2cc1OCCCS(C)(=O)=O

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
KDM4E B2RXH2 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
EHMT2 Q96KQ7 3/20 0.39
EHMT1 Q9H9B1 3/20 0.39
TNF P01375 1/20 0.38
MKNK1 Q9BUB5 3/20 0.37
ENPP1 P22413 1/20 0.37
EGFR P00533 2/20 0.37
PDGFRB P09619 3/20 0.36
PDGFRA P16234 3/20 0.36
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
SPIN1 Q9Y657 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501994 0.81 KDM4E (0.77) ALDH1A1KDM4ESMN1; SMN2ENPP1EGFR
SCHEMBL1010778 0.81 ALDH1A1 (1.00) ALDH1A1KDM4ESMN1; SMN2PDGFRBPDGFRA
SCHEMBL31352747 0.78 ALDH1A1 (0.81) ALDH1A1KDM4ESMN1; SMN2TNFENPP1
SCHEMBL2119205 0.77 ALDH1A1 (0.68) ALDH1A1KDM4ESMN1; SMN2KDR
SCHEMBL27349599 0.75 KDM4E (0.65) ALDH1A1KDM4ESMN1; SMN2EHMT2ENPP1
SCHEMBL1012226 0.75 ENPP1 (0.68) ENPP1KDR
SCHEMBL4373124 0.75 ENPP1 (0.68) ENPP1KDR
SCHEMBL27607881 0.73 KDM4E (0.58) ALDH1A1KDM4ESMN1; SMN2EHMT2EHMT1
SCHEMBL6030063 0.72 SMN1; SMN2 (0.68) ALDH1A1KDM4ESMN1; SMN2PDGFRBPDGFRA
SCHEMBL27352432 0.72 ALDH1A1 (0.69) ALDH1A1KDM4ESMN1; SMN2ENPP1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed